Anti-XKR8

Anti-XKR8
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
600-401-GA1 100 µg - -

6 - 10 Werktage*

848,00 €
 
Anti-XKR8 antibody was affinity purified from monospecific antiserum by immunoaffinity... mehr
Produktinformationen "Anti-XKR8"
Anti-XKR8 antibody was affinity purified from monospecific antiserum by immunoaffinity chromatography. XKR8 antibody is human reactive. At least two isoforms are known to exist, this antibody will detect both isoforms. Protein function: Probable regulator of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway, a signaling pathway that plays a pivotal role in tumor suppression by restricting proliferation and promoting apoptosis. Along with NF2 can synergistically induce the phosphorylation of LATS1 and LATS2 and can probably function in the regulation of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway. Acts as a transcriptional coactivator of ESR1 which plays an essential role in DYNLL1-mediated ESR1 transactivation. Regulates collagen-stimulated activation of the ERK/MAPK cascade. Modulates directional migration of podocytes. Acts as a substrate for PRKCZ. Plays a role in cognition and memory performance. [The UniProt Consortium]
Schlagworte: Anti-WWC1, Anti-KIBRA, Anti-KIAA0869, Anti-Protein KIBRA, Anti-HBeAg-binding protein 3, Anti-Kidney and brain protein, Anti-WW domain-containing protein 1
Hersteller: Rockland Immunochemicals
Hersteller-Nr: 600-401-GA1

Eigenschaften

Anwendung: ELISA, IHC, IFM, WB
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human
Immunogen: 15 amino acid peptide near the C-terminus of human XKR8.
Format: Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: -20°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-XKR8"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen